# Pancreatic Volume in Thalassemia: Determinants and Association with Alterations of Glucose Metabolism

**Authors:** Antonella Meloni, Gennaro Restaino, Vincenzo Positano, Laura Pistoia, Petra Keilberg, Michele Santodirocco, Anna Spasiano, Tommaso Casini, Marilena Serra, Emanuela De Marco, Maria Grazia Roberti, Sergio Bagnato, Alessia Pepe, Alberto Clemente, Massimiliano Missere

PMC · DOI: 10.3390/diagnostics15050568 · 2025-02-26

## TL;DR

This study found that pancreatic volume is reduced in thalassemia patients, and it is linked to iron levels and glucose metabolism issues, especially in beta-thalassemia major.

## Contribution

The study identifies pancreatic volume as a comparable predictor of glucose metabolism alterations to pancreatic iron in beta-thalassemia major.

## Key findings

- Pancreatic volume was significantly lower in both β-TI and β-TM patients compared to healthy subjects.
- Pancreatic iron was the main predictor of pancreatic volume in β-TM, while hepatic iron was in β-TI.
- In β-TM, reduced pancreatic volume was associated with altered glucose metabolism.

## Abstract

Objectives: This study aimed to compare the pancreatic volume between beta-thalassemia major (β-TM) and beta-thalassemia intermedia (β-TI) patients and between thalassemia patients and healthy subjects and to determine the predictors of pancreatic volume and its association with glucose metabolism in β-TM and β-TI patients. Methods: We considered 145 β-TM patients and 19 β-TI patients enrolled in the E-MIOT project and 20 healthy subjects. The pancreatic volume and pancreatic and hepatic iron levels were quantified by magnetic resonance imaging. Results: The pancreatic volume indexed by body surface area (PVI) was significantly lower in both β-TI and β-TM patients compared to healthy subjects and in β-TM patients compared to β-TI patients. The only independent determinants of PVI were pancreatic iron in β-TM and hepatic iron in β-TI. In β-TM, there was an association between alterations of glucose metabolism and PVI, and PVI was a comparable predictor of altered glucose metabolism compared to pancreatic iron. Only one β-TI patient had an altered glucose metabolism and showed a reduced PVI and pancreatic iron overload. Conclusions: Thalassemia syndromes are characterized by a reduced pancreatic volume, associated with iron levels. In β-TM, the pancreatic volume and iron deposition are associated with the development and progression of alterations of glucose metabolism.

## Linked entities

- **Diseases:** beta-thalassemia major (MONDO:0016486), beta-thalassemia intermedia (MONDO:0016487)

## Full-text entities

- **Diseases:** Pancreatic (MESH:D010195), beta-TI (MESH:D017086), Thalassemia (MESH:D013789), iron overload (MESH:D019190)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11899254/full.md

---
Source: https://tomesphere.com/paper/PMC11899254